116 related articles for article (PubMed ID: 2603984)
1. Role of calcium in U 46619 and PGF2 alpha pulmonary vasoconstriction in rat lungs.
Santoian EC; Angerio AD; Schneidkraut MJ; Ramwell PW; Kot PA
Am J Physiol; 1989 Dec; 257(6 Pt 2):H2001-5. PubMed ID: 2603984
[TBL] [Abstract][Full Text] [Related]
2. Calcium utilization associated with U-46619 and PGF2a vascular responses in rat lungs.
Santoian EC; Angerio AD; Schneidkraut MJ; Ramwell PW; Kot PA
Angiology; 1992 Feb; 43(2):163-8. PubMed ID: 1536478
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracellular and extracellular calcium blockers on the pulmonary vascular responses to PGF2 alpha and U46619.
Santoian EC; Angerio AD; Fitzpatrick TM; Rose JC; Ramwell PW; Kot PA
Angiology; 1987 Jan; 38(1 Pt 1):51-5. PubMed ID: 3468816
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin inhibitors and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate do not prevent the inhibitory effect of prostaglandin F2 alpha on cyclic AMP production in isolated rat corpora lutea.
Lahav M; Rennert H; Sabag K; Barzilai D
J Endocrinol; 1987 May; 113(2):205-12. PubMed ID: 3035050
[TBL] [Abstract][Full Text] [Related]
5. Effect of TMB-8 on the pulmonary vasoconstrictor action of prostaglandin F2 alpha and the thromboxane mimic, U 46619.
Angerio AD; Fitzpatrick TM; Kot PA; Ramwell PW; Rose JC; Santoian EC
Br J Pharmacol; 1982 Sep; 77(1):55-8. PubMed ID: 6957253
[TBL] [Abstract][Full Text] [Related]
6. Effect of verapamil on the pulmonary vasoconstrictor action of prostaglandin F2 alpha and a synthetic PGH2 analogue.
Angerio AD; Fitzpatrick TM; Kot PA; Ramwell PW; Rose JC
Br J Pharmacol; 1981 May; 73(1):101-3. PubMed ID: 7284690
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors.
Cooper CL; Shaffer JE; Malik KU
Circ Res; 1985 Jan; 56(1):97-108. PubMed ID: 3917874
[TBL] [Abstract][Full Text] [Related]
8. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Ca++ and calmodulin to the action of norepinephrine on renal prostaglandin synthesis and vascular tone.
Cooper CL; Malik KU
J Pharmacol Exp Ther; 1986 Feb; 236(2):424-31. PubMed ID: 3080585
[TBL] [Abstract][Full Text] [Related]
10. Effects of 8-epi-prostaglandin F2 alpha and U46,619 on pulmonary hemodynamics in piglets.
Truog WE; Norberg M; Thibeault DW
Biol Neonate; 1997; 71(5):306-16. PubMed ID: 9167852
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs.
Steudel W; Krämer HJ; Degner D; Rosseau S; Schütte H; Walmrath D; Seeger W
J Appl Physiol (1985); 1997 Jul; 83(1):18-24. PubMed ID: 9216939
[TBL] [Abstract][Full Text] [Related]
12. Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo.
Whittle BJ; Oren-Wolman N; Guth PH
Am J Physiol; 1985 May; 248(5 Pt 1):G580-6. PubMed ID: 2986466
[TBL] [Abstract][Full Text] [Related]
13. Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
Walker BR
Am J Physiol; 1995 Dec; 269(6 Pt 2):H2051-6. PubMed ID: 8594916
[TBL] [Abstract][Full Text] [Related]
14. Potassium channels are not involved in vasopressin-induced vasodilation in the rat lung.
Eichinger MR; Russ RD; Walker BR
Am J Physiol; 1994 Feb; 266(2 Pt 2):H491-5. PubMed ID: 8141349
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs.
Grimminger F; Spriestersbach R; Weissmann N; Walmrath D; Seeger W
J Appl Physiol (1985); 1995 Apr; 78(4):1509-15. PubMed ID: 7615463
[TBL] [Abstract][Full Text] [Related]
16. Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung.
Kang KH; Morrow JD; Roberts LJ; Newman JH; Banerjee M
J Appl Physiol (1985); 1993 Jan; 74(1):460-5. PubMed ID: 8444728
[TBL] [Abstract][Full Text] [Related]
17. Enhanced pulmonary alpha-2 adrenoceptor responsiveness under conditions of elevated pulmonary vascular tone.
Shebuski RJ; Ohlstein EH; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Jul; 242(1):158-65. PubMed ID: 3039109
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
Seale JP; Nourshargh S; Hellewell PG; Williams TJ
Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha augments pulmonary vasoconstriction via the inhibition of nitrovasodilator activity.
Johnson A; Ferro TJ
J Appl Physiol (1985); 1992 Dec; 73(6):2483-92. PubMed ID: 1490962
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in vasopressinergic pulmonary vasodilatation.
Russ RD; Walker BR
Am J Physiol; 1992 Mar; 262(3 Pt 2):H743-7. PubMed ID: 1558183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
